Startup WellTrackONE secures $1.5 million to improve Medicare wellness tests
Underneath Obamacare’s new stipulations, primary care providers are required to conduct wellness exams for their Medicare patients. With this in mind, WellTrackONE, the South-Carolina based healthcare startup, raised over 1.5 million from Easton Capital in order to better serve its patients with accessible and affordable testing options.
These wellness exams contain the standard details about patients’ health: height, weight, blood pressure and a brief overview of medical and family history. Neurological tests are also done, to ensure that patients are appropriately receiving preventative care as well as ongoing care for mental ailments like depression, Alzheimer’s or Dementia.
In an emailed response to questions, CEO Peter Bechtel said that so far, it is finding the most traction with accountable care organizations and integrated delivery networks.
“That has taken off like a rocket. What we bring to them is compelling: more revenue for their doctors, a method to significantly reduce healthcare cost by avoidance of catastrophic illness and injury, increase in ACO attribution, minable data for outcomes and clinical measures.”
He added that the startup expects to expand its staff from 19 to more than 50 by the end of the year.
Although the platform’s goal is to have 1,000 primary-care physicians on board, the organization is embracing accountable care organizations as a critical source of business. This new platform will handle patient outreach, evaluation and scheduling capabilities across a range of healthcare practices from primary-care practices to large healthcare organizations. Now, not only will patients have better access to their own healthcare information, but physicians will be able to do a better job of tracking their patients.
Along with its partners, myCatalyst works alongside WellTrackONE in order to enable an ACO to capture annual wellness visits and checkup data and integrate all of the findings into one health information exchange.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”